Another mechanistic pathway linking PCSK9 to AD, as shown in vitro, would be through canonical inhibition of local LDLR expression, resulting in decreased astrocyte-to-neuron cholesterol transport and reduced neuronal cholesterol content, thereby increasing Aβ neurotoxicity (96). The gene discussed is PCSK9; the disease is Alzheimer disease.